News

GlobalData on MSN23h

Prasad’s FDA exit may accelerate cell and gene therapy approvals

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...
BioSpace22h

New CDER Head Tidmarsh Will Sub In At Biologics Group After Prasad’s Exit

George Tidmarsh has only been at the Center for Drug Evaluation and Research for nine days, but will now add supervision of a ...
Healio23h

Oncologist who served as FDA’s chief medical officer, top vaccine official departs agency

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...